Literature DB >> 16026318

Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.

Gábor Szabó1, Susanne Bährle.   

Abstract

Ischemia and reperfusion injury leads to a complex pathophysiological process, which in turn results in the generation of free radicals. Peroxynitrite, a highly reactive species causes DNA single strand breaks, which activates the nuclear enzyme, poly (ADP-ribose) polymerase (PARP). The activation of PARP leads to an energy consuming inefficient repair cycle with subsequent depletion of NAD(+) and ATP pools and necrotic cell death. The present review overviews the pathophysiological role of the peroxynitrite-PARP pathway in cardiac ischemia/reperfusion injury with special reference to the therapeutic potential of PARP inhibitors in the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026318     DOI: 10.2174/1570161054368599

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  10 in total

1.  Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Authors:  Mohanraj Rajesh; Hao Pan; Partha Mukhopadhyay; Sándor Bátkai; Douglas Osei-Hyiaman; György Haskó; Lucas Liaudet; Bin Gao; Pál Pacher
Journal:  J Leukoc Biol       Date:  2007-07-25       Impact factor: 4.962

2.  Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.

Authors:  Tamás Radovits; Leila Seres; Domokos Gero; Irina Berger; Csaba Szabó; Matthias Karck; Gábor Szabó
Journal:  Exp Gerontol       Date:  2007-02-20       Impact factor: 4.032

3.  Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.

Authors:  Sándor Bátkai; Douglas Osei-Hyiaman; Hao Pan; Osama El-Assal; Mohanraj Rajesh; Partha Mukhopadhyay; Feng Hong; Judith Harvey-White; Anjum Jafri; György Haskó; John W Huffman; Bin Gao; George Kunos; Pál Pacher
Journal:  FASEB J       Date:  2007-02-27       Impact factor: 5.191

Review 4.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

5.  Hind limb ischemia-reperfusion injury in diet-induced obese mice.

Authors:  Hassan Albadawi; Rahmi Oklu; Nicholas R Cormier; Ryan M O'Keefe; James T Heaton; James B Kobler; William G Austen; Michael T Watkins
Journal:  J Surg Res       Date:  2014-01-17       Impact factor: 2.192

Review 6.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

7.  INO-4885 [5,10,15,20-tetra[N-(benzyl-4'-carboxylate)-2-pyridinium]-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice.

Authors:  Xiang-Ying Jiao; Erhe Gao; Yuexin Yuan; Yajing Wang; Wayne Bond Lau; Walter Koch; Xin-Liang Ma; Ling Tao
Journal:  J Pharmacol Exp Ther       Date:  2008-11-25       Impact factor: 4.030

8.  The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death.

Authors:  Shaun S Klassen; Simon W Rabkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-05       Impact factor: 3.000

Review 9.  Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects.

Authors:  Martin L Pall
Journal:  J Cell Mol Med       Date:  2013-06-26       Impact factor: 5.310

10.  The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury.

Authors:  Guang-Qing Huang; Jia-Ning Wang; Jun-Ming Tang; Lei Zhang; Fei Zheng; Jian-Ye Yang; Ling-Yun Guo; Xia Kong; Yong-Zhang Huang; Yong Liu; Shi-You Chen
Journal:  J Transl Med       Date:  2011-05-21       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.